112766 samples have been tested for influenza A H1N1 in government and private labs across India as of 1st Jan, 2010
Vigabatrin (Sabril) poses the high risk of permanent vision loss
VIAject, a rapid acting mealtime insulin to treat diabetes, is currently undergoing regulatory review in US, Biodel announced in a press release.